In the present article, Lindner et al. report on their single institutional, retrospective analysis of long-term outcomes after robotic sacrocolpopexy. 1 Approximately 90% of patients were free from repeat surgery at 6 years, and the 8.6% rate of recurrent prolapse requiring surgical intervention compares favorably with other series with shorter follow up. 2 However, as the authors note, the retrospective nature and non-uniform follow up in the study could obscure true recurrence rates insofar as patients might have been lost to follow up, particularly at a tertiary care institution. Nevertheless, patientreported outcomes at a median of 90 months follow up showed high rates of satisfaction with a median 9 out of 10 score with regard to symptomatic improvement. The high rate of symptomatic improvement and low incidence of recurrent prolapse surgery suggest durability of treatment.The series also shows a relatively low rate of mesh complication with just two patients (2.7%) suffering vaginal mesh extrusion, comparable with other published series with shortand medium-term follow up. 3 Retroperitonealization of the polypropylene mesh and preservation of the cervix likely contribute to low rates of mesh complication. Given the recent controversy regarding use of mesh in transvaginal prolapse surgery, the low rate of mesh complication in this longterm follow-up series reaffirms the safety of mesh use in robotic sacrocolpopexy.It is important to note that the current study population was somewhat limited. No patients possessed a body mass index >30, just three patients (4.3%) were diabetic and two patients (2.9%) were smokers. Indeed, this patient population might not be representative of the typical index patient who undergoes robotic sacrocolpopexy, particularly given the associations between the aforementioned factors and pelvic organ prolapse. 4 Additionally, the authors excluded 14 patients (17%) who required conversion to open sacrocolpopexy; the results for these patients are reported elsewhere and are notable for a correlation between elevated body mass index and the need for conversion. 5 This relatively high rate of conversion relative to other published series suggests a need for continued careful patient selection and further investigation of risk factors for conversion. 3 Overall, robotic sacrocolpopexy is a highly safe and effective procedure for the treatment of apical prolapse. Despite its limitations, the current study adds to the growing body of literature in support of this procedure, and is among the first to show durability of treatment for the long-term follow-up period.
References1 Linder BJ, Chow GK, Elliott DS. Long-term quality of life outcomes and retreatment rates after robotic sacrocolpopexy. Int. J. Urol. 2015; 22: 1155-8. 2 Germain A, Thibault F, Galifet M et al. Long-term outcomes after totally robotic sacrocolpopexy for treatment of pelvic organ prolapse. Surg. Endosc. 2013; 27: 525-9. 3 Lee RK, Mottrie A, Payne CK, Waltregny D. A review of the current status of laparoscopic and robot-as...